Actinium Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinical Development

The MarketWatch News Department was not involved in the creation of this content.

NEW YORK, Dec. 1, 2020 /PRNewswire via COMTEX/ —
NEW YORK, Dec. 1, 2020 /PRNewswire/ — Actinium Pharmaceuticals, Inc.  (NYSE AMERICAN: ATNM) (“Actinium” or the “Company”) today announced the appointment of Mary Mei Chen, M.D., Ph.D. to the position of Vice President of Clinical Development, effective immediately. In this role, Dr. Chen will lead the clinical development of Actinium’s CD33 program including the Actimab-A plus CLAG-M and Actimab-A plus venetoclax combination trials in relapsed and refractory Acute Myeloid Leukemia (“R/R AML”). Dr. Chen joins Actinium from GlycoMimetics, where she played a leading role in multiple clinical trials including the global pivotal Phase 3 study of uproleselan (GMI-1271-301). In addition to working on Actimab-A development, Dr. Chen will also utilize her training in immunology and experience in translational medicine to identify areas of synergy between targeted radiotherapy with

Read More

Asperitas Appoints New Research and Development Director

AMSTERDAM, Nov. 23, 2020 — Immersion cooling specialist Asperitas announces that Andy Young has joined the management team as Director of Research & Development.

Andy is well-known within the industry, bringing an in-depth knowledge of immersion technology to the role. With a background in mechanical engineering, his career boasts positions at Ansys and also Iceotope, where he was the Head of Fluids and Thermal Engineering. He also remains active in the OCP community as part of the Advanced Cooling sub-project. Andy’s appointment follows on from the role of Merijn Koster, who has led the technical developments at Asperitas since 2018. Merijn will stay for the remainder of 2020 to ensure a smooth transfer and will be moving on to pastures new in 2021. Andy will become part of the Management Team within Asperitas and will be responsible for all new product development projects.

Andy Young

“I’m excited to start at

Read More

MRI Software Appoints Saurabh Abhyankar as Chief Product Officer

SOLON, Ohio, Nov. 11, 2020 /PRNewswire/ — MRI Software (“MRI”), a global leader in real estate software solutions, announces the appointment of Saurabh Abhyankar as Chief Product Officer (CPO). In this role, Abhyankar will lead MRI’s global product strategy and drive the continued innovation and evolution of the company’s open and connected software platform for the real estate industry.

Saurabh Abhyankar

Abhyankar has a strong track record over the last 15 years of inventing and bringing new products to market, building and leading product management teams, and driving revenue and adoption. He was most recently at MicroStrategy, holding a number of leadership positions including Chief Product Officer and SVP of Product Management, managing a broad portfolio of analytics products. Previously, he held senior product management leadership roles at SAP, where he worked in the Paris office for 12 years.

“I’m very excited to welcome Saurabh to MRI’s executive team during

Read More